标题
The Role of EREG/EGFR Pathway in Tumor Progression
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 23, Pages 12828
出版商
MDPI AG
发表日期
2021-12-01
DOI
10.3390/ijms222312828
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation
- (2021) Florien Westendorp et al. ONCOGENE
- Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts
- (2021) Mireia Berdiel-Acer et al. ONCOGENE
- Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer
- (2021) Shiqi Ma et al. ONCOGENE
- Artificial intelligence-assisted amphiregulin and epiregulin immunohistochemistry predicts panitumumab benefit in RAS wild-type metastatic colorectal cancer
- (2021) Christopher J M Williams et al. CLINICAL CANCER RESEARCH
- Pancancer survival analysis of cancer hallmark genes
- (2021) Ádám Nagy et al. Scientific Reports
- Neuregulins in Neurodegenerative Diseases
- (2021) Guan-yong Ou et al. Frontiers in Aging Neuroscience
- Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas
- (2021) Wei-jiang Zhao et al. Frontiers in Immunology
- 3-Nitrobenzanthrone promotes malignant transformation in human lung epithelial cells through the epiregulin-signaling pathway
- (2021) Kuan-Yuan Chen et al. CELL BIOLOGY AND TOXICOLOGY
- Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
- (2021) Kyu Sic You et al. Pharmaceuticals
- Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices
- (2020) Pengfei Xia et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
- (2020) Cheng-Yi Lin et al. ONCOLOGY
- EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer
- (2020) Vito Amodio et al. Cancer Discovery
- Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
- (2020) Zeda Zhang et al. CANCER CELL
- ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications
- (2020) Wook Jin Journal of Clinical Medicine
- Tumor-Associated Macrophage Status in Cancer Treatment
- (2020) Anna Maria Malfitano et al. Cancers
- Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
- (2020) Qing-Hai Li et al. Gastroenterology Report
- LINC00885 a Novel Oncogenic Long Non-Coding RNA Associated with Early Stage Breast Cancer Progression
- (2020) Martin C. Abba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
- (2020) David S. Hong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated epiregulin expression predicts poor prognosis in gastric cancer
- (2019) Qiuyan Xia et al. PATHOLOGY RESEARCH AND PRACTICE
- The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan
- (2019) Chien-Hua Tseng et al. Journal of Thoracic Oncology
- EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: implications for combination therapies
- (2019) Yijun Jia et al. INTERNATIONAL JOURNAL OF CANCER
- The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
- (2019) Mengjia He et al. ONCOGENE
- Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
- (2019) Yujia Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction
- (2019) Sylvie Job et al. Cancers
- Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
- (2019) Anqi Lin et al. Molecular Cancer
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells
- (2019) Shanwen Chen et al. CANCER LETTERS
- On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity
- (2019) Ada Ledonne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Contribution of Angiogenesis to Inflammation and Cancer
- (2019) Dolores Aguilar-Cazares et al. Frontiers in Oncology
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer
- (2018) Jenny F. Seligmann et al. JAMA Oncology
- Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer
- (2018) Felix Bormann et al. INTERNATIONAL JOURNAL OF CANCER
- β‐Catenin‐RAS interaction serves as a molecular switch for RAS degradation via GSK3β
- (2018) Sang‐Kyu Lee et al. EMBO REPORTS
- Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab
- (2018) Yasunao Kogashiwa et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors
- (2018) David Argyle et al. Frontiers in Immunology
- Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial
- (2018) Sebastian Stintzing et al. Frontiers in Oncology
- Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
- (2017) Yi-Long Wu et al. LUNG CANCER
- The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland
- (2017) Aleksander D Szymaniak et al. eLife
- ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology
- (2017) Nico Jacobi et al. Cancers
- Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
- (2016) Michael S Lee et al. BRITISH JOURNAL OF CANCER
- Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis
- (2016) Sihua Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
- (2016) Susan D Richman et al. JOURNAL OF PATHOLOGY
- Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model
- (2016) Alison K. Bauer et al. MOLECULAR CARCINOGENESIS
- Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter
- (2016) X Qu et al. ONCOGENE
- Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters
- (2016) Kevin J. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma
- (2016) Shuli Liu et al. Oncotarget
- Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients
- (2016) Chen Jing et al. Oncotarget
- Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
- (2016) Ben Zhao et al. Oncotarget
- Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
- (2016) Hung-Chih Hsu et al. Oncotarget
- Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients WithRASWild-Type Advanced Colorectal Cancer
- (2016) Jenny F. Seligmann et al. JAMA Oncology
- Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
- (2015) S.Y. Brulé et al. EUROPEAN JOURNAL OF CANCER
- Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines
- (2015) AS Yar Saglam et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)
- (2015) A. Stahler et al. INTERNATIONAL JOURNAL OF CANCER
- Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival
- (2015) Mariya Farooqui et al. Molecular Cancer
- Yap-dependent reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer
- (2015) Alex Gregorieff et al. NATURE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
- (2014) E. Missiaglia et al. ANNALS OF ONCOLOGY
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- KAP1 Promotes Proliferation and Metastatic Progression of Breast Cancer Cells
- (2014) J. B. Addison et al. CANCER RESEARCH
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Epiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma
- (2014) Shinji Kohsaka et al. NEURO-ONCOLOGY
- Epiregulin: Roles in normal physiology and cancer
- (2014) David J. Riese et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
- (2013) George Pentheroudakis et al. BMC CANCER
- High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor
- (2013) Gregor Auf et al. BMC CANCER
- Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
- (2013) D J Jonker et al. BRITISH JOURNAL OF CANCER
- The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies
- (2013) Claudia Esposito et al. CANCER BIOLOGY & THERAPY
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Tumor fibroblast–derived epiregulin promotes growth of colitis-associated neoplasms through ERK
- (2013) Clemens Neufert et al. JOURNAL OF CLINICAL INVESTIGATION
- Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
- (2013) Matthew T Seymour et al. LANCET ONCOLOGY
- The clinicopathological significance of Lgr5 expression in lung adenocarcinoma
- (2013) Shinichiro Ryuge et al. LUNG CANCER
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transformation of polarized epithelial cells by apical mistrafficking of epiregulin
- (2013) B. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
- (2012) Zu-Yao Yang et al. Journal of Hematology & Oncology
- Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers
- (2012) Jiyeon Yun et al. LABORATORY INVESTIGATION
- HER family receptor and ligand status in thymic carcinoma
- (2012) Annikka Weissferdt et al. LUNG CANCER
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer
- (2012) N Sunaga et al. ONCOGENE
- LGR5-Positive Colon Cancer Stem Cells Interconvert with Drug-Resistant LGR5-Negative cells and are Capable of Tumor Reconstitution
- (2012) Shinta Kobayashi et al. STEM CELLS
- PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- (2011) C. Mao et al. ANNALS OF ONCOLOGY
- Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
- (2011) J B Baker et al. BRITISH JOURNAL OF CANCER
- Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
- (2011) Claire L. Vale et al. CANCER TREATMENT REVIEWS
- Epiregulin as a marker for the initial steps of ovarian cancer development
- (2011) Abraham Amsterdam INTERNATIONAL JOURNAL OF ONCOLOGY
- Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes
- (2010) Toshiaki Watanabe et al. EUROPEAN JOURNAL OF CANCER
- Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics
- (2010) Xiao-Dong Li et al. ONKOLOGIE
- Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells
- (2009) Meng Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
- (2009) Lucia Regales et al. JOURNAL OF CLINICAL INVESTIGATION
- Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab
- (2009) Bart Jacobs et al. JOURNAL OF CLINICAL ONCOLOGY
- PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
- (2008) F. Perrone et al. ANNALS OF ONCOLOGY
- Intratumoral Epiregulin Is a Marker of Advanced Disease in Non-Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells
- (2008) J. Zhang et al. Cancer Prevention Research
- Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
- (2008) Shigeki Higashiyama et al. CANCER SCIENCE
- Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Cancer Cells
- (2008) R. Bianco et al. CLINICAL CANCER RESEARCH
- ErbBs in lung cancer
- (2008) Sreenath V. Sharma et al. EXPERIMENTAL CELL RESEARCH
- AP-2α and AP-2γ regulate tumor progression via specific genetic programs
- (2008) Francesca Orso et al. FASEB JOURNAL
- The epidermal growth factor receptor ligands at a glance
- (2008) Marlon R. Schneider et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes
- (2008) Xingya Wang et al. MOLECULAR CARCINOGENESIS
- Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt
- (2008) Kai Hu et al. ORAL ONCOLOGY
- Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome
- (2008) Sashwati Roy et al. PHYSIOLOGICAL GENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started